JOSEPH BRINDISI: Open Payments
NPI 1902322340 · BUFFALO, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$528 in 31 payments from 6 companies in 2025. Trend: 2023 $488 · 2024 $546 · 2025 $528
Food & beverage: $528
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 9 | $179 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 13 | $141 |
| ABBVIE INC. | 5 | $107 |
| Madrigal Pharmaceuticals | 2 | $60 |
| Intercept Pharmaceuticals, Inc. | 1 | $24 |
| Orexo US, Inc. | 1 | $16 |
Products named: XIFAXAN, REZDIFFRA, MAVYRET, UBRELVY, OCALIVA, DALVANCE, Zubsolv.
Industry payments across NY — which companies pay providers there.
